Eichner 2020.
Study name | A Community‐based Assessment of Skin Care, Allergies, and Eczema (CASCADE) |
Methods | Pragmatic, multi‐site, randomised, community‐based trial |
Participants | Estimated enrolment: 1250 |
Interventions | Experimental: daily emollient Parents assigned to the intervention arm will receive a lipid‐rich emollient and educational materials promoting once‐daily full‐body emollient use until the infant is 24 months old. Parents will select 1 of 5 emollients to be mailed to the dyad's home at enrolment and approximately every 6 months for the duration of the study. These emollients include (1) CeraVe Healing Ointment, (2) Vaseline, (3) Cetaphil Cream, (4) CeraVe Cream, and (5) Vanicream Intervention: other: participant choice of over‐the‐counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe Cream, Cetaphil Cream Comparator: no Intervention, natural skin Parents assigned to the control arm will receive educational materials promoting general infant skin care guidelines only and will be asked to refrain from emollient use unless dry skin develops (current standard of care guidelines) |
Outcomes |
Primary outcome Cumulative incidence of AD [Time Frame: 24 months] Secondary outcomes
|
Starting date | 3 July 2018 |
Contact information | LeAnn Michaels ‐ michaell@ohsu.edu Clara Stemwedel ‐ stemwedc@ohsu.edu |
Notes |